Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Opportunities and challenges of CD47-targeted therapy in cancer immunotherapy
Q. Chen, XUEJUN GUO, Wenxue Ma
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 32, Iss. 1, pp. 49-60
Open Access | Times Cited: 23

Showing 23 citing articles:

Cytokines and soluble mediators as architects of tumor microenvironment reprogramming in cancer therapy
Suling Xu, Qing-Qing Wang, Wenxue Ma
Cytokine & Growth Factor Reviews (2024) Vol. 76, pp. 12-21
Closed Access | Times Cited: 12
The next frontier in immunotherapy: potential and challenges of CAR-macrophages
Jing Li, Ping Chen, Wenxue Ma
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Engineering Exosomes for Therapeutic Applications: Decoding Biogenesis, Content Modification, and Cargo Loading Strategies
Mehrnoosh Bahadorani, Mahboobeh Nasiri, Kristen Dellinger, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 7137-7164
Open Access | Times Cited: 8
Promising Therapeutic Strategies for Hematologic Malignancies: Innovations and Potential
Jan Jakub Lica, Bhaskar Pradhan, Kawthar Safi, et al.
Molecules (2024) Vol. 29, Iss. 17, pp. 4280-4280
Open Access | Times Cited: 5
Crosstalk of SPINK4 Expression With Patient Mortality, Immunotherapy and Metastasis in Pan-Cancer Based on Integrated Multi-Omics Analyses
Xiuhua Cao, Na Luo, Xiaoyan Liu, et al.
OncoTargets and Therapy (2025) Vol. Volume 18, pp. 161-177
Open Access
Human Embryonic Kidney HEK293 Cells as a Model to Study SMVT-Independent Transport of Biotin and Biotin-Furnished Nanoparticles in Targeted Therapy
Magdalena Twardowska, Andrzej Łyskowski, Maria Misiorek, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1594-1594
Open Access
In vitro ovarian tumor-conditioned CD163+ human macrophages retain phagocytic response to CD47 blockade
Kristian W. Antonsen, Anne G. Jensen, Boe Sandahl Sørensen, et al.
Cellular Immunology (2025) Vol. 409-410, pp. 104932-104932
Open Access
CAR T Cells in Lung Cancer: Targeting Tumor-Associated Antigens to Revolutionize Immunotherapy
Sattam Khulaif Alenezi
Pathology - Research and Practice (2025), pp. 155947-155947
Closed Access
Multi-Omics Analysis of the Immune Effect of the Engineered Exosome Drug Delivery System in Inducing Macrophage Apoptosis
Wei Xiang, Zhoujun Zhu, Qisong Shang, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 494-494
Open Access
Progress in cancer research on the regulator of phagocytosis CD47, which determines the fate of tumor cells (Review)
Fan Wu, Hongyuan Pang, Fan Li, et al.
Oncology Letters (2024) Vol. 27, Iss. 6
Open Access | Times Cited: 3
CD39 transforming cancer therapy by modulating tumor microenvironment
Suling Xu, Yuhan Ma, Xinyu Jiang, et al.
Cancer Letters (2024) Vol. 597, pp. 217072-217072
Open Access | Times Cited: 2
GREM1 may be a biological indicator and potential target of bladder cancer
Qingxin Yu, Shanshan Xu, Shouxiang Weng, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Relationship between clonal evolution and drug resistance in bladder cancer: A genomic research review
Zhouting Tuo, Ying Zhang, Dengxiong Li, et al.
Pharmacological Research (2024) Vol. 206, pp. 107302-107302
Open Access | Times Cited: 1
Breaking Boundaries: Immunotherapy for Myeloid Malignancies
T. N. Gavrilova, Eduard Schulz, Alain Mina
Cancers (2024) Vol. 16, Iss. 16, pp. 2780-2780
Open Access | Times Cited: 1
Unleashing the potential of CD39-targeted cancer therapy: Breaking new ground and future prospects
Qiongyan Zhou, Shengwen Shao, Theia Minev, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117285-117285
Open Access | Times Cited: 1
Recent advancements and challenges in 3D bioprinting for cancer applications
Swayam Aryam Behera, Binita Nanda, P. Ganga Raju Achary
Bioprinting (2024) Vol. 43, pp. e00357-e00357
Closed Access | Times Cited: 1
Translating CD47-Targeted Therapy in Gastrointestinal Cancers: Insights from Preclinical to Clinical Studies
Changgan Chen, Fengchun Lu, Heguang Huang, et al.
iScience (2024) Vol. 27, Iss. 12, pp. 111478-111478
Open Access | Times Cited: 1
Advancing the next generation of cancer treatment with circular RNAs in CAR-T cell therapy
Sanxiong Huang, Juling Xu, Natalia Baran, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 181, pp. 117753-117753
Open Access | Times Cited: 1
The Immune Response of Cancer Cells in Breast and Gynecologic Neoplasms
Katarzyna Rakoczy, Justyna Kaczor, Adam Sołtyk, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6206-6206
Open Access
The advances in targeting CD47/SIRPα “do not eat me” axis and their ongoing challenges as an anticancer therapy
Maria Gracia-Hernandez, Manasa Suresh, Alejandro Villagra
Oncotarget (2024) Vol. 15, Iss. 1, pp. 462-465
Open Access
The Prognostic Significance of CD47, CD68, and CD163 Expression Levels and Their Relationship with MLR and MAR in Locally Advanced and Oligometastatic Nasopharyngeal Carcinoma
Asım Armağan Aydın, Ramazan Oğuz Yüceer, Şenay Yıldırım, et al.
Diagnostics (2024) Vol. 14, Iss. 23, pp. 2648-2648
Open Access
Electrochemical sensors for the detection of immune checkpoint related proteins and their role in cancer companion diagnostics
Louise Barnaby, Andrew G. Watts, Pedro Estrela
Biosensors and Bioelectronics X (2024), pp. 100561-100561
Open Access
Smart Cell Therapy: an industry perspective on macrophages as living drugs
David T. Rodgers, Tatiana I. Novobrantseva, Rita N. Bárcia
Cytotherapy (2024)
Closed Access
Investigating the role of CD47 gene regulation in Iraqi cancer patients: a promising prognostic factor
Shilan Jabbar, Athraa Ismael
Iraqi Journal of Cancer and Medical Genetics (2023) Vol. 16, Iss. 2
Open Access | Times Cited: 1
Page 1

Scroll to top